JP2015511613A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015511613A5 JP2015511613A5 JP2015502285A JP2015502285A JP2015511613A5 JP 2015511613 A5 JP2015511613 A5 JP 2015511613A5 JP 2015502285 A JP2015502285 A JP 2015502285A JP 2015502285 A JP2015502285 A JP 2015502285A JP 2015511613 A5 JP2015511613 A5 JP 2015511613A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- replaced
- cycloalkyl
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000001072 heteroaryl group Chemical group 0.000 claims 38
- 125000000623 heterocyclic group Chemical group 0.000 claims 37
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 27
- 229910052757 nitrogen Inorganic materials 0.000 claims 24
- 125000000217 alkyl group Chemical group 0.000 claims 22
- 229920006395 saturated elastomer Polymers 0.000 claims 22
- 125000000753 cycloalkyl group Chemical group 0.000 claims 20
- 125000005842 heteroatom Chemical group 0.000 claims 19
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 18
- 125000006704 (C5-C6) cycloalkyl group Chemical group 0.000 claims 15
- 229910052799 carbon Inorganic materials 0.000 claims 14
- 229910052739 hydrogen Inorganic materials 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 12
- 125000001153 fluoro group Chemical group F* 0.000 claims 12
- 150000003839 salts Chemical class 0.000 claims 12
- 125000001424 substituent group Chemical group 0.000 claims 11
- 125000003831 tetrazolyl group Chemical group 0.000 claims 11
- -1 phenyl -O- Chemical class 0.000 claims 10
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 8
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims 7
- 229910052760 oxygen Inorganic materials 0.000 claims 7
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 125000006705 (C5-C7) cycloalkyl group Chemical group 0.000 claims 5
- 125000003118 aryl group Chemical group 0.000 claims 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 4
- 125000004429 atom Chemical group 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- 208000008589 Obesity Diseases 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 2
- 208000016097 disease of metabolism Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 208000030159 metabolic disease Diseases 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- 238000007363 ring formation reaction Methods 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- 125000006645 (C3-C4) cycloalkyl group Chemical group 0.000 claims 1
- 125000006555 (C3-C5) cycloalkyl group Chemical group 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 208000032928 Dyslipidaemia Diseases 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 206010022489 Insulin Resistance Diseases 0.000 claims 1
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 1
- 206010033307 Overweight Diseases 0.000 claims 1
- 239000003472 antidiabetic agent Substances 0.000 claims 1
- 229940125708 antidiabetic agent Drugs 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 230000002503 metabolic effect Effects 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12161240 | 2012-03-26 | ||
| EP12161240.2 | 2012-03-26 | ||
| PCT/EP2013/056313 WO2013144098A1 (en) | 2012-03-26 | 2013-03-25 | New indanyloxydihydrobenzofuranylacetic acid derivatives and their use as gpr40 receptor agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015511613A JP2015511613A (ja) | 2015-04-20 |
| JP2015511613A5 true JP2015511613A5 (OSRAM) | 2016-05-19 |
| JP6131492B2 JP6131492B2 (ja) | 2017-05-24 |
Family
ID=48013980
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015502284A Active JP6040486B2 (ja) | 2012-03-26 | 2013-03-25 | 新しいインダニルオキシジヒドロベンゾフラニル酢酸誘導体およびｇｐｒ４０受容体作動薬としてのそれらの使用 |
| JP2015502285A Active JP6131492B2 (ja) | 2012-03-26 | 2013-03-25 | 新しいインダニルオキシジヒドロベンゾフラニル酢酸誘導体およびｇｐｒ４０受容体作動薬としてのそれらの使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015502284A Active JP6040486B2 (ja) | 2012-03-26 | 2013-03-25 | 新しいインダニルオキシジヒドロベンゾフラニル酢酸誘導体およびｇｐｒ４０受容体作動薬としてのそれらの使用 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US8642585B2 (OSRAM) |
| EP (2) | EP2831064B1 (OSRAM) |
| JP (2) | JP6040486B2 (OSRAM) |
| KR (1) | KR20140139088A (OSRAM) |
| CN (1) | CN104321319A (OSRAM) |
| AP (1) | AP2014007903A0 (OSRAM) |
| AR (1) | AR090493A1 (OSRAM) |
| AU (1) | AU2013241926A1 (OSRAM) |
| CA (1) | CA2868474A1 (OSRAM) |
| CL (1) | CL2014002556A1 (OSRAM) |
| CO (1) | CO7091175A2 (OSRAM) |
| EA (1) | EA201401053A1 (OSRAM) |
| EC (1) | ECSP14023238A (OSRAM) |
| HK (1) | HK1201260A1 (OSRAM) |
| MA (1) | MA20150065A1 (OSRAM) |
| MX (1) | MX2014011465A (OSRAM) |
| PE (1) | PE20142019A1 (OSRAM) |
| PH (1) | PH12014502141A1 (OSRAM) |
| SG (1) | SG11201405713UA (OSRAM) |
| TN (1) | TN2014000398A1 (OSRAM) |
| TW (1) | TW201400466A (OSRAM) |
| UY (1) | UY34704A (OSRAM) |
| WO (2) | WO2013144097A1 (OSRAM) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2546154T3 (es) * | 2010-12-01 | 2015-09-21 | Boehringer Ingelheim International Gmbh | Ácidos indaniloxidihidrobenzofuranilacéticos, útiles para el tratamiento del síndrome metabólico |
| US8642585B2 (en) * | 2012-03-26 | 2014-02-04 | Boehringer Ingelheim International Gmbh | Indanyloxydihydrobenzofuranylacetic acids |
| EP3036237A4 (en) * | 2013-08-23 | 2017-01-25 | Fujian Haixi Pharmaceuticals Co. Ltd | Carboxylic acid compounds in treatment of diabetes mellitus |
| EA201690888A1 (ru) | 2013-11-14 | 2016-10-31 | Кадила Хелзкэр Лимитед | Новые гетероциклические соединения |
| WO2015084692A1 (en) | 2013-12-04 | 2015-06-11 | Merck Sharp & Dohme Corp. | Antidiabetic bicyclic compounds |
| EP3102198B1 (en) | 2014-02-06 | 2020-08-26 | Merck Sharp & Dohme Corp. | Antidiabetic compounds |
| US10100042B2 (en) | 2014-08-08 | 2018-10-16 | Merck Sharp & Dohme Corp. | [5,6]—fused bicyclic antidiabetic compounds |
| EP3347358B1 (en) * | 2015-09-09 | 2019-11-27 | Boehringer Ingelheim International GmbH | [{[2,3-dihydro-1h-inden-1-yl]amino}-2h,3h-furo[3,2-b]pyridin-3-yl]acetic acids, pharmaceutical compositions and uses thereof |
| JP7008704B2 (ja) | 2016-11-28 | 2022-01-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | インダニルアミノピリジルシクロプロパンカルボン酸、その医薬組成物及び使用 |
| JP6968181B2 (ja) | 2017-01-26 | 2021-11-17 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | インダニルアミノピラジニルシクロプロパンカルボン酸、その医薬組成物及び使用 |
| CN110198928B (zh) | 2017-01-26 | 2023-08-29 | 勃林格殷格翰国际有限公司 | 苄氧基吡啶基环丙烷甲酸、其药物组合物和用途 |
| CN110312714B (zh) | 2017-01-26 | 2022-12-09 | 勃林格殷格翰国际有限公司 | 苄基氧基吡嗪基环丙烷甲酸、其药物组合物和用途 |
| JP7049349B2 (ja) | 2017-01-26 | 2022-04-06 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ベンジルアミノピラジニルシクロプロパンカルボン酸、その医薬組成物及び使用 |
| US10919859B2 (en) | 2017-01-26 | 2021-02-16 | Boehringer Ingelheim International Gmbh | Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof |
| CN110300755B (zh) * | 2017-02-08 | 2022-10-04 | 勃林格殷格翰国际有限公司 | 茚满基氨基氮杂二氢苯并呋喃乙酸、用于治疗糖尿病的药物组合物 |
| US11186565B2 (en) | 2017-03-31 | 2021-11-30 | Takeda Pharmaceutical Company Limited | Aromatic compound |
| US11078146B2 (en) | 2017-12-04 | 2021-08-03 | Basf Se | Method for preparing ethers of cycloaliphatic or araliphatic diols |
| WO2019149959A1 (en) * | 2018-02-05 | 2019-08-08 | Glaxosmithkline Intellectual Property Development Limited | Ghrelin o-acyltransferase inhibitors |
| MY196582A (en) | 2018-02-13 | 2023-04-19 | Gilead Sciences Inc | PD-1/PD-L1 Inhibitors |
| CA3093851A1 (en) | 2018-03-29 | 2019-10-03 | Arbutus Biopharma Corporation | Substituted 1,1'-biphenyl compounds, analogues thereof, and methods using same |
| WO2019204609A1 (en) | 2018-04-19 | 2019-10-24 | Gilead Sciences, Inc. | Pd-1/pd-l1 inhibitors |
| PT3820572T (pt) | 2018-07-13 | 2023-11-10 | Gilead Sciences Inc | Inibidores pd-1/pd-l1 |
| EP3843711A4 (en) * | 2018-08-29 | 2022-08-03 | ChemoCentryx, Inc. | METHODS OF CANCER TREATMENT WITH SMALL MOLECULE PD-L1 INHIBITORS |
| TW202028183A (zh) * | 2018-10-10 | 2020-08-01 | 大陸商江蘇豪森藥業集團有限公司 | 含氮雜芳類衍生物調節劑、其製備方法和應用 |
| EP3870566A1 (en) | 2018-10-24 | 2021-09-01 | Gilead Sciences, Inc. | Pd-1/pd-l1 inhibitors |
| KR20220150270A (ko) | 2019-10-07 | 2022-11-10 | 칼리오페, 인크. | Gpr119 효능제 |
| JP7745559B2 (ja) | 2020-02-28 | 2025-09-29 | キャリーオペ，インク． | Ｇｐｒ４０アゴニスト |
| BR112022023359A2 (pt) | 2020-05-19 | 2023-04-18 | Kallyope Inc | Ativadores de ampk |
| JP2023531726A (ja) | 2020-06-26 | 2023-07-25 | キャリーオペ，インク． | Ａｍｐｋアクチベーター |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4594611B2 (ja) * | 2002-11-08 | 2010-12-08 | 武田薬品工業株式会社 | 受容体機能調節剤 |
| CA2505322A1 (en) * | 2002-11-08 | 2004-05-21 | Takeda Pharmaceutical Company Limited | Receptor function regulator |
| CN1735408A (zh) * | 2002-11-08 | 2006-02-15 | 武田药品工业株式会社 | 受体机能调节剂 |
| JP4805552B2 (ja) * | 2003-05-30 | 2011-11-02 | 武田薬品工業株式会社 | 縮合環化合物 |
| US7820837B2 (en) | 2003-05-30 | 2010-10-26 | Takeda Pharmaceutical Company Limited | Condensed ring compound |
| JPWO2007114213A1 (ja) | 2006-03-30 | 2009-08-13 | 旭化成ファーマ株式会社 | 置換二環式環状誘導体及びその用途 |
| EP2431367A3 (en) | 2006-06-27 | 2012-07-04 | Takeda Pharmaceutical Company Limited | Fused cyclic compounds as GPR40 receptor modulators |
| WO2009157418A1 (ja) | 2008-06-25 | 2009-12-30 | 第一三共株式会社 | カルボン酸化合物 |
| AU2009303475B2 (en) | 2008-10-15 | 2012-09-13 | Amgen Inc. | Spirocyclic GPR40 modulators |
| WO2010143733A1 (en) | 2009-06-09 | 2010-12-16 | Takeda Pharmaceutical Company Limited | Novel fused cyclic compound and use thereof |
| TW201643169A (zh) * | 2010-07-09 | 2016-12-16 | 艾伯維股份有限公司 | 作為s1p調節劑的螺-哌啶衍生物 |
| ES2546154T3 (es) | 2010-12-01 | 2015-09-21 | Boehringer Ingelheim International Gmbh | Ácidos indaniloxidihidrobenzofuranilacéticos, útiles para el tratamiento del síndrome metabólico |
| US8642585B2 (en) * | 2012-03-26 | 2014-02-04 | Boehringer Ingelheim International Gmbh | Indanyloxydihydrobenzofuranylacetic acids |
-
2013
- 2013-03-14 US US13/803,237 patent/US8642585B2/en active Active
- 2013-03-22 UY UY0001034704A patent/UY34704A/es unknown
- 2013-03-25 PE PE2014001462A patent/PE20142019A1/es not_active Application Discontinuation
- 2013-03-25 EA EA201401053A patent/EA201401053A1/ru unknown
- 2013-03-25 KR KR20147030011A patent/KR20140139088A/ko not_active Withdrawn
- 2013-03-25 MX MX2014011465A patent/MX2014011465A/es unknown
- 2013-03-25 AP AP2014007903A patent/AP2014007903A0/xx unknown
- 2013-03-25 TW TW102110560A patent/TW201400466A/zh unknown
- 2013-03-25 CA CA2868474A patent/CA2868474A1/en not_active Abandoned
- 2013-03-25 MA MA37429A patent/MA20150065A1/fr unknown
- 2013-03-25 WO PCT/EP2013/056312 patent/WO2013144097A1/en not_active Ceased
- 2013-03-25 EP EP13712760.1A patent/EP2831064B1/en active Active
- 2013-03-25 EP EP13724175.8A patent/EP2831053B1/en active Active
- 2013-03-25 JP JP2015502284A patent/JP6040486B2/ja active Active
- 2013-03-25 AR ARP130100969A patent/AR090493A1/es unknown
- 2013-03-25 WO PCT/EP2013/056313 patent/WO2013144098A1/en not_active Ceased
- 2013-03-25 HK HK15101722.6A patent/HK1201260A1/xx unknown
- 2013-03-25 AU AU2013241926A patent/AU2013241926A1/en not_active Abandoned
- 2013-03-25 JP JP2015502285A patent/JP6131492B2/ja active Active
- 2013-03-25 SG SG11201405713UA patent/SG11201405713UA/en unknown
- 2013-03-25 CN CN201380026597.0A patent/CN104321319A/zh active Pending
-
2014
- 2014-09-22 TN TNP2014000398A patent/TN2014000398A1/fr unknown
- 2014-09-25 PH PH12014502141A patent/PH12014502141A1/en unknown
- 2014-09-25 CL CL2014002556A patent/CL2014002556A1/es unknown
- 2014-09-26 CO CO14213969A patent/CO7091175A2/es unknown
- 2014-10-17 EC ECIEPI201423238A patent/ECSP14023238A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015511613A5 (OSRAM) | ||
| JP2019031560A5 (OSRAM) | ||
| JP2016520618A5 (OSRAM) | ||
| JP2017503760A5 (OSRAM) | ||
| JP2018536648A5 (OSRAM) | ||
| JP2005526028A5 (OSRAM) | ||
| JP2013509442A5 (OSRAM) | ||
| JP2016503797A5 (OSRAM) | ||
| JP2011519863A5 (OSRAM) | ||
| JP2016505551A5 (OSRAM) | ||
| JP2016509594A5 (OSRAM) | ||
| JP2013507423A5 (OSRAM) | ||
| JP2014521688A5 (OSRAM) | ||
| JP2010504286A5 (OSRAM) | ||
| JP2015504067A5 (OSRAM) | ||
| JP2012513416A5 (OSRAM) | ||
| JP2013512277A5 (OSRAM) | ||
| JP2018526405A5 (OSRAM) | ||
| RU2018134948A (ru) | Бициклические арильные монобактамовые соединения и способы их применения для лечения бактериальных инфекций | |
| JP2012512863A5 (OSRAM) | ||
| JP2014516070A5 (OSRAM) | ||
| JP2016508506A5 (OSRAM) | ||
| JP2014510147A5 (OSRAM) | ||
| JP2011520775A5 (OSRAM) | ||
| JP2009518365A5 (OSRAM) |